Consensus conference on acute bronchiolitis (v): Prevention of acute bronchiolitis. Review of scientific evidence;Conferencia de Consenso sobre bronquiolitis aguda (V): Prevención de la bronquiolitis aguda. Revisión de la evidencia cientfica

Anales de Pediatria

Volumn 72, Issue 5, 2010, Pages

  Gonzalez De Dios J ^a   Ochoa Sangrador, C ^b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b HOSPITAL VIRGEN DE LA CONCHA   (Spain)

Author keywords

Consensus development conference; Pediatrics; Systematic review; Viral bronchiolitis prevention

Indexed keywords

ADRENALIN; BECLOMETASONE; BUDESONIDE; CORTICOSTEROID; DEXAMETHASONE; FLUTICASONE; IMMUNOGLOBULIN; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PALIVIZUMAB; PLACEBO; PREDNISOLONE; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY;

ARTIFICIAL VENTILATION; BRONCHIOLITIS; CONGENITAL HEART DISEASE; DISEASE TRANSMISSION; DRUG COST; DRUG EFFICACY; HAND WASHING; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE UNIT; LUNG DYSPLASIA; MORTALITY; OXYGEN THERAPY; PREMATURITY; RECURRENT INFECTION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RISK BENEFIT ANALYSIS; SECONDARY PREVENTION; TREATMENT DURATION; WHEEZING;

EID: 77952240516     PISSN: 16954033     EISSN: 16959531     Source Type: Journal    
DOI: 10.1016/j.anpedi.2009.12.018     Document Type: Article

References (94)

1. J. Gonzlez de Dios, and C. Ochoa Sangrador Grupo Revisor y Panel de Expertos de la Conferencia de Consenso del Proyecto aBREVIADo. Recomendaciones de la Conferencia de Consenso sobre Bronquiolitis aguda An Pediatr (Barc) 72 2010 221.e1 221.e33
2. N. Sigurs, P.M. Gustafsson, R. Bjarnason, F. Lundberg, S. Schmidt, and F. Sigurbergsson Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13 Am J Respir Crit Care Med 171 2005 137 141
3. R.T. Stein, D. Sherrill, W.J. Morgan, C.J. Holberg, M. Halonen, and L.M. Taussig Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years Lancet 354 1999 541 545
4. E.G. Perez-Yarza, A. Moreno, P. Lzaro, A. Mejias, and O. Ramilo The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature Pediatr Infect Dis J 26 2007 733 739
5. F. Martnez, A. Wright, L. Taussig, C. Holberg, M. Halonen, W. Morgan The Group Health Medical Associates Asthma and wheezing in the first six years of life N Engl J Med 332 1995 133 138
6. L. Taussig, A. Wright, C. Holberg, M. Halonen, W. Morgan, and F. Martnez Tucson Children's Respiratory Study: 1980 to present J Allergy Clin Immunol 111 2003 661 675
7. J. Castro-Rodrguez, C. Holberg, A. Wrigth, and F. Martnez A Clinical Index to define risk of asthma in young children with recurrent wheezing Am J Respir Crit Care Med 162 2000 1403 1406
8. T. Guilbert, W. Morgan, R. Zeiger, L. Bacharier, S. Boehmer, and M. Krawiec Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma J Allergy Clin Immunol 114 2004 1282 1287
9. C.E. Kuehni Phenotype specific treatment of obstructive airways disease in infancy and childhood: new recommendations of the Swiss Paediatric Pulmonology Group Swiss Med Wkly 135 2005 95 100
10. J. Castillo, J. De Benito, A. Escribano, M. Fernndez, S. Garca de la Rubia, and J. Garde Grupo de trabajo de para el Consenso sobre Tratamiento del Asma Infantil. Consenso sobre tratamiento del asma en Pediatría An Pediatr (Barc) 67 2007 253 273
11. E. Prez-Yarza, O. Sardn Prado, and J. Korta Murua Sibilancias recurrentes en menores de tres aos: evidencias y oportunidades An Pediatr (Barc) 69 2008 369 382
12. I. beda Sansano, J. Murcia Garca, and J. Castillo Laita Tratamiento de las sibilancias recurrentes/asma en el nio menor de 3 aos de edad Rev Pediatr Aten Primaria 11 2009 97 120
13. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn Prevention of respiratory syncytial virus infections: indications for the use of palivizumab update on the use of RSV-IGIV Pediatrics 102 1998 1211 1216
14. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections Pediatrics 112 2003 1442 1446
15. X. Carbonell Estrany, J. Quero Jimenez Standards Committee of the Spanish Society of Neonatology. Board of Directors of the Spanish Society of Neonatology Recommendations for the prevention of respiratory syncytial virus infections An Esp Pediatr 52 2000 372 374 (Pubitemid 32385489)
16. X. Carbonell-Estrany, and J. Quero Jimenez Guidelines for respiratory syncytial virus prophylaxis. An update An Esp Pediatr 56 2002 334 336
17. J. Figueras Aloy, J. Quero, E. Domenech, M.C. Lpez Herrera, I. Izquierdo, and A. Losada Recommendations for the prevention of respiratory syncytial virus infection An Pediatr (Barc) 63 2005 357 362
18. F. Puigvents Latorre, F. Comas Gallardo, O. Delgado Snchez, and I. Martnez Lpez Utilizacin de evaluaciones econmicas de intervenciones sanitarias: el caso palivizumab Med Clin (Barc) 123 2004 758
19. I. Danes Carreras, and J.M. Arnau De Bolos Prophylaxis of respiratory syncytial virus infections with palivizumab An Esp Pediatr 56 2002 289 291
20. J. Gonzlez de Dios, and C. Ochoa Sangrador Palivizumab y bronquiolitis: necesidad de aplicar la eficiencia para adecuar la prctica clnica a las pruebas cientficas Med Clin (Barc) 124 2005 478 479
21. J. Figueras Aloy, J. Lpez Sastre, C. Medrano Lpez, R. Bermdez-Caete Fernndez, L. Fernndez Pineda, and A. Bonillo Perales Consenso multidisciplinar espaol sobre la profilaxis de la infeccin respiratoria peditrica por virus respiratorio sincitial An Pediatr (Barc) 69 2008 63 71
22. K.K. Macartney, M.H. Gorelick, M.L. Manning, R.L. Hodinka, and L.M. Bell Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control Pediatrics 106 2000 520 526
23. T. Guilbert, W. Morgan, R. Zeiger, D. Mauger, S. Boehmer, and S. Szfler Long-term inhaled corticosteroids in preschool children at high risk for asthma N Engl J Med 354 2006 1985 1997
24. H. Bisgaard, D. Sci, M. Hermansen, L. Loland, L. Halkjaer, and F. Buchvald Intermittent inhaled corticosteroids in infants with episodic wheezing N Engl J Med 354 2006 1998 2005
25. C. Murray, A. Woodcock, S. Langley, J. Morris, A. Custovic IFWIN study team Secondary prevention of asthma by the use of Inhaled Fluticasone propionate in Wheezy IN-fants (IFWIN): Double-blind, randomised, controlled study Lancet 368 2006 754 762
26. P. Brand, E. Baraldi, and H. Bisgaard Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach Eur Respir J 32 2008 1010 1096
27. M. Ermers, M. Rovers, J. Van Voensel, J. Kimpen, J. Bont RSV Corticosteroid Study Group The effect of high dose inhaled corticosteroids on wheeze in infants alter respiratory syncytial virus infection: randomised double blind placebo controlled trial BMJ 338 2009 b897
28. H. Richter, and P. Seddon Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing J Pediatr 132 1998 849 853
29. A. Cade, K.G. Brownlee, S.P. Conway, D. Haigh, A. Short, and J. Brown Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis Arch Dis Child 82 2000 126 130
30. L. Bentur, D. Shoseyov, D. Feigenbaum, Y. Gorichovsky, and H. Bibi Dexamethasone inhalations in RSV bronchiolitis: a double-blind, placebo-controlled study Acta Paediatr 94 2005 866 871
31. K. Carlsen, J. Leegaard, S. Larsen, and I. Orstavik Nebulised beclomethasone dipropionate in recurrent obstructive episodes after acute bronchiolitis Arch Dis Child 63 1988 1428 1433
32. T. Reijonen, M. Korppi, L. Kuikka, and K. Remes Anti-inflammatory therapy reduces wheezing after bronchiolitis Arch Pediatr Adolesc Med 150 1996 512 517
33. G.F. Fox, M.L. Everard, M.J. Marsh, and A.D. Milner Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing Arch Dis Child 80 1999 343 347
34. M. Kajosaari, P. Syvanen, M. Forars, and K. Juntunen-Backman Inhaled corticosteroids during and after respiratory syncytial virus-bronchiolitis may decrease subsequent asthma Pediatr Allergy Immunol 11 2000 198 202
35. J.Y. Wong, S. Moon, C. Beardsmore, C. O'Callaghan, and H. Simpson No objective benefit from steroids inhaled via a spacer in infants recovering from bronchiolitis Eur Respir J 15 2000 388 394
36. M. Callen Blecua, P. Aizpurua Galdeano, I. Ozcoidi Erro, L. Mancisidor Aguinagalde, C. Guedea Adiego, and E. Busselo Ortega Inhaled corticosteroids and wheezing post-bronchiolitis An Esp Pediatr 52 2000 351 355
37. D. Blom, M. Ermers, L. Bont, W.M. van Aalderen, and J.B. van Woensel Inhaled corticosteroids during acute bronchiolitis in the prevention of post-bronchiolitic wheezing Cochrane Database Syst Rev 2007 CD004881
38. J. Castro-Rodrguez, and G. Rodrigo Efficacy of inhaled corticosteroids in infants and preschoolers with recurrent wheezing and asthma: a systematic review with meta-analysis Pediatrics 123 2009 e519 e525
39. I. Berger, Z. Argaman, S.B. Schwartz, E. Segal, A. Kiderman, and D. Branski Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up Pediatr Pulmonol 26 1998 162 166
40. J.B. Van Woensel, J.L. Kimpen, A.B. Sprikkelman, A. Ouwehand, and W.M. van Aalderen Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus Pediatr Pulmonol 30 2000 92 96
41. L. Zhang, E. Ferruzzi, T. Bonfanti, M.I. Auler, N.E. D'Avila, and C.S. Faria Long and short-term effect of prednisolone in hospitalized infants with acute bronchiolitis J Paediatr Child Health 39 2003 548 551
42. S.M. Blow, N.M., E. Levin, B. Friis, L.L. Thomsen, and J.E. Nielsen Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants Pediatrics 104 1999 e147
43. H. Bisgaard A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis Am J Respir Crit Care Med 167 2003 379 383
44. H. Bisgaard, A. Flores-Nunez, A. Goh, P. Azimi, A. Halkas, and M. Malice Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children Am J Respir Crit Care Med 178 2008 854 860
45. L. Richeldi, G. Ferrara, L. Fabbri, T. Lasserson, and P. Gibson Macrolides for chronic asthma Cochrane Database Syst Rev 20 2005 CD002997
46. A. Mnica Fonseca, P. Okada, K. Bowlare, S. Chvez Bueno, A. Mejas, and A. Ros Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: A double-blind, randomized, placebo-controlled trial Ann Allergy Asthma Immunol 97 2006 457 463
47. J.R. Groothuis, E.A. Simoes, M.J. Levin, C.B. Hall, C.E. Long, W.J. Rodriguez The Respiratory Syncytial Virus Immune Globulin Study Group Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children N Engl J Med 329 1993 1524 1530
48. E.A. Simoes, H.M. Sondheimer, F.H. Top Jr., H.C. Meissner, R.C. Welliver, A.A. Kramer The Cardiac Study Group Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease J Pediatr 133 1998 492 499
49. The PREVENT Study Group Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis Pediatrics 99 1997 93 99
50. E.E. Wang, and N.K. Tang Immunoglobulin for preventing respiratory syncytial virus infection Cochrane Database Syst Rev 2000 CD001725
51. The IMpact-RSV Study Group Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants Pediatrics 102 1998 531 537
52. E.E. Wang, B.J. Law, and D. Stephens Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection J Pediatr 126 1995 212 219
53. D.K. Shay, R.C. Holman, G.E. Roosevelt, M.J. Clarke, and L.J. Anderson Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997 J Infect Dis 183 2001 16 22
54. J. Handforth, M. Sharland, and J.S. Friedland Prevention of respiratory syncytial virus infection in infants BMJ 328 2004 1026 1027
55. T. Heikkinen, H. Valkonen, L. Lehtonen, R. Vainionpaa, and O. Ruuskanen Hospital admission of high risk infants for respiratory syncytial virus infection: implications for palivizumab prophylaxis Arch Dis Child Fetal Neonatal Ed 90 2005 F64 F68
56. H.C. Meissner Uncertainty in the management of viral lower respiratory tract disease Pediatrics 108 2001 1000 1003
57. J. Gonzlez de Dios, and C. Ochoa Sangrador Palivizumab and bronchiolitis: need to apply the efficiency in order to join clinical practice to scientific studies Med Clin (Barc) 124 2005 478 479
58. T.F. Feltes, A.K. Cabalka, H.C. Meissner, F.M. Piazza, D.A. Carlin, and F.H. Top Jr Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease J Pediatr 143 2003 532 540
59. K. Giebels, J.E. Marcotte, J. Podoba, C. Rousseau, M.H. Denis, and V. Fauvel Prophylaxis against respiratory syncytial virus in young children with cystic fibrosis Pediatr Pulmonol 43 2008 169 174
60. M. Grimaldi, B. Gouyon, P. Sagot, C. Quantin, F. Huet, and J.B. Gouyon Palivizumab efficacy in preterm infants with gestational age < or=30 weeks without bronchopulmonary dysplasia Pediatr Pulmonol 42 2007 189 192
61. I. Mitchell, S. Tough, L. Gillis, and C. Majaesic Beyond randomized controlled trials: a "real life" experience of respiratory syncytial virus infection prevention in infancy with and without palivizumab Pediatr Pulmonol 41 2006 1167 1174
62. C. Pedraz, X. Carbonell-Estrany, J. Figueras-Aloy, and J. Quero Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants Pediatr Infect Dis J 22 2003 823 827
63. E.A. Simoes, J.R. Groothuis, X. Carbonell-Estrany, C.H. Rieger, I. Mitchell, and L.M. Fredrick Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing J Pediatr 151 2007 34, e1 42, e1
64. R. Singleton, L. Dooley, D. Bruden, S. Raelson, and J.C. Butler Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants Pediatr Infect Dis J 22 2003 540 545
65. R.J. Singleton, D. Bruden, L.R. Bulkow, G. Varney, and J.C. Butler Decline in respiratory syncytial virus hospitalizations in a region with high hospitalization rates and prolonged season Pediatr Infect Dis J 25 2006 1116 1122
66. E. Henckel, J. Luthander, E. Berggren, H. Kapadia, L. Naver, and M. Norman Palivizumab prophylaxis and hospitalization for respiratory syncytial virus disease in the Stockholm infant population, 1999 through 2002 Pediatr Infect Dis J 23 2004 27 31
67. T. Lacaze-Masmonteil, J. Seidenberg, I. Mitchell, V. Cossey, M. Cihar, and M. Csader Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection Drug Saf 26 2003 283 291
68. C. Parnes, J. Guillermin, R. Habersang, P. Nicholes, V. Chawla, and T. Kelly Palivizumab prophylaxis of respiratory syncytial virus disease in 20002001: results from The Palivizumab Outcomes Registry Pediatr Pulmonol 35 2003 484 489
69. B. Resch, W. Gusenleitner, W.D. Muller, and J. Haas Observational study of respiratory syncytial virus-associated hospitalizations and use of palivizumab in premature infants aged 2932 weeks Eur J Clin Microbiol Infect Dis 25 2006 120 122
70. C. Medrano, L. Garca-Guereta, J. Grueso, B. Insa, F. Ballesteros, and J. Casaldaliga Respiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic Study Cardiol Young 17 2007 360 371
71. G. Boivin, G. Caouette, L. Frenette, J. Carbonneau, M. Ouakki, and G. De Serres Human respiratory syncytial virus and other viral infections in infants receiving palivizumab J Clin Virol 2007
72. S.A. Cohen, R. Zanni, A. Cohen, M. Harrington, P. Vanveldhuisen, and M.L. Boron Palivizumab use in subjects with congenital heart disease: Results from the 20002004 Palivizumab Outcomes Registry Pediatric Cardiology 29 2008 382 387
73. Grupo de Hospitales Benazuza Quimioprofilaxis con palivizumab en Andaluca. Resultados de la epidemia de VRS 20002001 An Esp Pediatr 56 2002 293 297
74. L. Naver, M. Eriksson, U. Ewald, A. Linde, M. Lindroth, and J. Schollin Appropriate prophylaxis with restrictive palivizumab regimen in preterm children in Sweden Acta Paediatr 93 2004 1470 1473
75. P.I. Oh, K.L. Lanctjt, A. Yoon, D.S. Lee, B.A. Paes, and B.S. Simmons Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes Pediatr Infect Dis J 21 2002 512 518
76. J. Romero Palivizumab prophylaxis of respiratory syncytial virus disease from 19982002: results from four years of palivizumab usage Pediatr Infect Dis J 22 2003 S46 S54
77. T. Saji, M. Nakazawa, and K. Harada Safety and efficacy of palivizumab prophylaxis in children with congenital heart disease Pediatr Int 47 2005 397 403
78. M. Sorrentino, T. Powers The Palivizumab Outcomes Study Group Effectiveness of palivizumab: evaluation of outcomes from the 19981999 respiratory syncytial virus season Pediatr Infect Dis J 19 2000 1068 1071
79. R.A. Cox, P. Rao, and C. Brandon-Cox The use of palivizumab monoclonal antibody to control an outbreak of respiratory syncytial virus infection in a special care baby unit J Hosp Infect 48 2001 186 192
80. C. Abadesso, H.I. Almeida, D. Virella, M.H. Carreiro, and M.C. Machado Use of palivizumab to control an outbreak of syncytial respiratory virus in a neonatal intensive care unit J Hosp Infect 58 2004 38 41
81. J. Mansbach, S. Kunz, U. Acholonu, S. Clark, and C.A. Camargo Jr Evaluation of compliance with palivizumab recommendations in a multicenter study of young children presenting to the emergency department with bronchiolitis Pediatr Emerg Care 23 2007 362 367
82. D. Prais, D. Danino, T. Schonfeld, and J. Amir Impact of palivizumab on admission to the ICU for respiratory syncytial virus bronchiolitis: a national survey Chest 128 2005 2765 2771
83. J.P. DeVincenzo, J. Aitken, and L. Harrison Respiratory syncytial virus (RSV) loads in premature infants with and without prophylactic RSV fusion protein monoclonal antibody J Pediatr 143 2003 123 126
84. J.M. Geskey, G.D. Ceneviva, G.L. Brummel, G.R. Graff, and M.C. Javier Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit? Clin Ther 26 2004 2130 2137
85. A. Bonillo Perales, J. Dez Delgado Rubio, A. Ortega Montes, P. Infante Marquez, M. Jimenez Liria, J. Batlles Garrido Comparacin con el ImpactRSV Study Group Antecedentes perinatales y hospitalizacin por bronquiolitis An Esp Pediatr 53 2000 527 532
86. S.M. Prado, P.C. Perret, P.L. Montecinos, B.A. Veloz, P.N. Le Corre, and A.L. Habash Human metapneumovirus as hospitalization cause in children under 3 years old with acute respiratory infections during 2004 Rev Chilena Infectol 24 2007 19 26
87. American Academy of Pediatrics (AAP) Subcommittee on Diagnosis and Management of Bronchiolitis Diagnosis and management of bronchiolitis Pediatrics 118 2006 1774 1793
88. SIGN. Bronchiolitis in children. A national clinical guideline. Available at: http://www.sign.ac.uk. 2006.
89. Bronchiolitis Guideline Team, Cincinnati Children's Hospital Medical Center. Evidence based clinical practice guideline for medical management of bronchiolitis in infants year of age or less presenting with a first time episode. Cincinnati: Cincinnati Children's Hospital Medical Center; 2005. [cited 22 August 2006]. Available from url: http://www.cincinnatichildrens.org/NR/ rdonlyres/0B7B99D7-DB3E-4186-B2FC-71539E23421E/0/bronchiolitisguideline.pdf
90. J. Groothuis, J. Bauman, F. Malinoski, and M. Eggleston Strategies for prevention of RSV nosocomial infection J Perinatol 28 2008 319 323
91. R.A. Kilani Respiratory syncytial virus (RSV) outbreak in the NICU: description of eight cases J Trop Pediatr 48 2002 118 122
92. A.T. Heerens, D.D. Marshall, and C.L. Bose Nosocomial respiratory syncytial virus: a threat in the modern neonatal intensive care unit J Perinatol 22 2002 306 307
93. S.N. Blow, M. Nir, E. Levin, B. Friis, L. Thomsen, and J. Nielsen Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants Pediatrics 104 1999 e147
94. T. Lacaze-Masmonteil, P. Truffert, D. Pinquier, P. Daoud, G. Goldfarb, and E. Vicaut Lower respiratory tract illness and RSV prophylaxis in very premature infants Arch Dis Child 89 2004 562 567